MURRAY REPORT✉ Free Email News Alerts← world desk
NEWS   /   WORLD NEWS

MHRA launches new programme to tackle evidence gaps on women’s health

Photograph accompanying MHRA launches new programme to tackle evidence gaps on women’s health (source: UK Government)
UK Government — publisher photograph (see original for photographer credit)

Women’s Health Programme aims to support innovation in women’s health and better understand how the risks and benefits of medicines and medical devices may differ for women.

Women are set to benefit from better evidence on medicines and medical devices, including how their risks and benefits may differ for women, under a new programme launched today by the Medicines and Healthcare products Regulatory Agency (MHRA).

Despite making up 51% of the population, women continue to face gaps in research and treatment across a range of health conditions. They have historically been underrepresented in clinical research, limiting the evidence available on medicines and medical devices during pregnancy and across reproductive health. Unmet needs also remain for conditions specific to women, as well as those that present differently or disproportionately in women.

An MHRA analysis of all 4,616 UK clinical trial applications submitted between 2019 and 2023 highlighted continuing gaps in representation. Pregnant women were represented in just 1.1% of trials, while breastfeeding women were represented in 0.6%.

The Women’s Health Programme aims to address these challenges and explore how better data and scientific advancements can more accurately reflect women’s needs.